Fixing Europe (again)Well ladies and gentlemen of the biotechnology community, welcome back after the silly season. I hope you had a nice one, whether it was in the sunny bit, the rainy bit or the bits that were on fire. … more ➔
Is Europe truly ready for a bioeconomy?Bioeconomy is the new health, and that is official. You only have to look at all the planning for Horizon 2020 and all the big words coming out of politicians at national and European levels to see that. … more ➔
Erik Bogsch: Biosimilars and biologics for...Twenty-eight percent of the products given marketing authorisation between November 2010 and October 2011 in the US and one-third of all the new drugs in the EU have biotechnological origins. And experts … more ➔
Solving the debt with biotechGood news! After some thinking, I’ve solved the eurocrisis and saved national investment in biotechnology! As with most people who champion a single Europe, what is going to happen in the eurozone weighs … more ➔
François Busquet: Why Europe needs the Hu...What is the Human Toxome Project? It’s a wide-reaching programme aimed at helping us to reconsider how hazard/risk assessment has been performed over the last 50 years on marketed substances like chemicals, … more ➔
For real innovation, the pieces of the puz...I co-chaired a session at the Commission’s Innovation in Healthcare’ conference recently, and learned a very interesting lesson there that is overwhelmingly obvious, yet overlooked in our continuing … more ➔
Marc de Garidel: Personalised medicine th...In the last 30 years, biotechnology has become a major source of innovation in combating untreated diseases and improving current treatments. A better understanding of the human genome rests at the heart … more ➔
Kurt Zatloukal: New framework for global r...The increase in lifestyle and ageing-associated diseases that has paralleled a rise in drug development costs along with the financial constraints of the global economy is putting enormous pressure … more ➔
Do the clouds on the pharma horizon have a...If Jane Austen was writing in the early 21st century in Europe, she could well have begun one of her novels with: It is a truth universally acknowledged, that a country in possession of a biotech sector, … more ➔
Maive Rute: Your role in establishing the...The societal and economic challenges facing Europe and the world are complex and interconnected. The Bioeconomy Strategy and Action Plan “Innovating for Sustainable Growth: a Bioeconomy for Europe”, … more ➔
